Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Visibility
Worldnewswire
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
99
100
Next >
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
August 12, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
John B. Sanfilippo & Son, Inc. 4th Quarter Fiscal Year 2026 Operating Results Conference Call
August 12, 2026
From
John B. Sanfilippo & Son, Inc.
Via
GlobeNewswire
Tickers
JBSS
Toppoint Holdings Inc. Reports Second Quarter 2026 Financial Results
August 12, 2026
From
Toppoint Holdings Inc
Via
GlobeNewswire
Toppoint Holdings Inc. Comments on Unusual Trading Activity
August 12, 2026
From
Toppoint Holdings Inc
Via
GlobeNewswire
Gaxos Delivers Record Second-Quarter Revenue, Up 35.8% Sequentially and 1,337% Year over Year
August 12, 2026
From
GAXOS.AI INC.
Via
GlobeNewswire
Tickers
GXAI
Skaergaard’s 2026 Resource Used a $3,500 Gold Assumption; Gold Has Since Traded Above $4,300
August 12, 2026
From
Energy Metal News
Via
GlobeNewswire
Tickers
AEM
GRML
KGC
NEM
WPM
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
August 12, 2026
From
Zealand Pharma
Via
GlobeNewswire
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
From
Connect Biopharma Holdings Limited
Via
GlobeNewswire
Tickers
CNTB
Coherent Corp. Reports Fourth Quarter and Full Year Fiscal 2026 Results
August 12, 2026
From
Coherent Corp.
Via
GlobeNewswire
Tickers
COHR
Lumexa Imaging Announces Second Quarter 2026 Results
August 12, 2026
From
Lumexa Imaging Holdings, Inc.
Via
GlobeNewswire
Tickers
LMRI
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 12, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Cerebras Systems Fast Inference Cloud Business Nearly Quadruples in Second Quarter 2026
August 12, 2026
From
Cerebras Systems Inc.
Via
GlobeNewswire
Tickers
CBRS
MaxCyte Reports Second Quarter 2026 Financial Results
August 12, 2026
From
MaxCyte, Inc
Via
GlobeNewswire
Tickers
MXCT
Comscore Reports Second Quarter 2026 Results
August 12, 2026
From
Comscore, Inc.
Via
GlobeNewswire
Tickers
SCOR
Enovix Reports Second Quarter 2026 Results
August 12, 2026
From
Enovix Corporation
Via
GlobeNewswire
Tickers
ENVX
ENVXW
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
August 12, 2026
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
ITG, Inc. Reports Second Quarter 2026 Results
August 12, 2026
From
ITG, Inc.
Via
GlobeNewswire
Tickers
ITG
Robinhood Markets, Inc. Reports July 2026 Operating Data
August 12, 2026
From
Robinhood Markets, Inc.
Via
GlobeNewswire
Tickers
HOOD
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
AVIR
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
August 12, 2026
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ALLO
Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts
August 12, 2026
From
Acrivon Therapeutics, Inc
Via
GlobeNewswire
Tickers
ACRV
Liftoff Mobile Announces Second Quarter 2026 Financial Results
August 12, 2026
From
Liftoff Mobile
Via
GlobeNewswire
Tickers
LFTO
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MVST
August 12, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Tickers
MVST
Acquisition of Own Shares
August 12, 2026
From
Lakefront Biotherapeutics
Via
GlobeNewswire
Arhaus Announces Participation in Upcoming Investor Conferences
August 12, 2026
From
Arhaus, Inc.
Via
GlobeNewswire
Tickers
ARHS
Hyperion DeFi Reports 2Q 2026 Financial Results with Another Record Quarterly Net Income and Strong Operating Momentum
August 12, 2026
From
Hyperion DeFi, Inc.
Via
GlobeNewswire
Tickers
HYPD
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
August 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2026 Financial Results
August 12, 2026
From
Grocery Outlet, Inc.
Via
GlobeNewswire
Tickers
GO
Usio Announces Second Quarter 2026 Financial Results
August 12, 2026
From
Usio, Inc.
Via
GlobeNewswire
Tickers
USIO
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.